SCHEMBL7908193

SCHEMBL7908193

COC(=O)[C@H](C)NC(=O)c1cccc([N+](=O)[O-])c1N

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 6/20 0.48
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
TSHR P16473 1/20 0.44
CTSD P07339 1/20 0.44
HTT P42858 1/20 0.43
KCNMA1 Q12791 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP2C9 P11712 1/20 0.41
DHODH Q02127 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7475632 0.88 GLA (0.53) GLASMN1; SMN2ALDH1A1CYP1A2POLB
SCHEMBL7475644 0.88 GLA (0.53) GLASMN1; SMN2ALDH1A1CYP1A2POLB
SCHEMBL31530473 0.86 ALDH1A1 (0.59) GLASMN1; SMN2ALDH1A1CYP1A2POLB
SCHEMBL31530477 0.86 ALDH1A1 (0.59) GLASMN1; SMN2ALDH1A1CYP1A2POLB
SCHEMBL5248182 0.79 SLC6A2 (0.58) GLASMN1; SMN2ALDH1A1CYP1A2POLB
SCHEMBL308242 0.79 TSHR (0.53) GLASMN1; SMN2ALDH1A1CYP1A2POLB
SCHEMBL7908196 0.77 SMN1; SMN2 (0.55) GLASMN1; SMN2ALDH1A1CYP1A2POLB
SCHEMBL7904464 0.77 ALDH1A1 (0.49) ALDH1A1CYP3A4TSHRHTTKCNMA1
SCHEMBL7904396 0.75 CTSD (0.47) GLASMN1; SMN2ALDH1A1CYP1A2POLB
SCHEMBL631453 0.75 ALDH1A1 (0.57) ALDH1A1CYP1A2CYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
CN-1034122-C Antiviral tetrahydroimioazo [1,4] benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA NV (BE) 1997-02-26 CN disclosed
CN-1031058-C Antiviral tetrahydroimidazo [1,4]-benzodiazepin-2-ones JANSSEN PHARMACEUTICA NV (BE) 1996-02-21 CN disclosed
CN-1029848-C Process for preparing tetrahydroimidazo [1,4] benzodiazepin-2-thiones JANSSEN PHARMACEUTICA NV (BE) 1995-09-27 CN disclosed
CN-1057840-A New antiviral imidazolidine is [1,4] benzodiazepine-2-(sulphur) ketone also JANSSEN PHARMACEUTICA NV (BE) 1992-01-15 CN disclosed
CN-1045105-A Imidazolidine is the preparation method of [1,4] benzodiazepine-2-thioketones also JANSSEN PHARMACEUTICA NV (BE) 1990-09-05 CN disclosed
CN-1036957-A It is antiviral with imidazolidine [1,4] benzodiazepine-2-ketone compounds also, JANSSEN PHARMACEUTICA NV (BE) 1989-11-08 CN disclosed